← All opportunities
Breakthrough T1D · United States
Mitigating Stress-related Cell Loss in Islet Replacement Therapy for Type 1 Diabetes (T1D) Open
Applications close on 19 Nov 2026.
Deadline 19 Nov 2026 (in 4 days) Grant amount Not stated — see the official call Funding rate Charity research award; costs set by the RFA Likely applicant types Universities & research, Non-profits From source categories or programme rules; the call decides. Funder Breakthrough T1D (charity) Reference Breakthrough T1D: Mitigating Stress-related Cell Loss in Islet Replacement Therapy for Typ Last checked 15 Nov 2026
Open the official call ↗ Add deadline to calendar
Timing Letters of Intent due 19 Nov 2026, 5:00pm US Eastern (as stated)
How to apply Apply through the funder’s official page (link below); it states the procedure, documents and deadline. From the call text Who can apply Not stated in the call text we hold — check the official page Company stage Not stated in the call text we hold — check the official page Single applicant or consortium Not stated in the call text we hold — check the official page Where applicants must be based Not stated in the call text we hold — check the official page Where to apply Not stated in the call text we hold — check the official page
Where these facts come from Fact Value How we know Taken from the source Deadline 19 November 2026“Letters of Intent due 19 Nov 2026, 5:00pm US Eastern (as stated)” read from the official page 15 Nov 2026 Amount per applicant Unknown — not stated in the source we hold unknown — Total budget Unknown — not stated in the source we hold unknown — Funding rate Charity research award; costs set by the RFA read from the official text 15 Nov 2026 Who can apply Unknown — not stated in the source we hold unknown — Where to apply Unknown — not stated in the source we hold unknown —
Official sources Official call page · Request for applications (PDF)
Facts on this page were read from the official page on 15 Nov 2026. The funder's own documents, including later amendments, always take precedence.
Related funding Breakthrough T1D United States Breakthrough T1D: Common Mechanisms in Autoimmunity Insight Awards
Mitigating Stress-related Cell Loss in Islet Replacement Therapy for Type 1 Diabetes (T1D)
Open Deadline 7 Jan 2027 (in 53 days)
Grant amount Not stated — see the official call
Funding rate Charity research award; costs set by the RFA
View details → Breakthrough T1D United States Breakthrough T1D: Project Concepts (Strategic Research Agreement), Round 2
A rolling submission for the institutional support of scientific meetings, conferences, and workshops relevant to the Breakthrough T1D mission. Individual conference atte…
Open Deadline 6 May 2027 (in 172 days)
Grant amount Not stated — see the official call
Funding rate Charity research award; costs set by the RFA
View details → Breakthrough T1D United States Breakthrough T1D: Conference Awards
A rolling submission for the institutional support of scientific meetings, conferences, and workshops relevant to the Breakthrough T1D mission. Individual conference atte…
Rolling — apply any time Deadline No fixed deadline
Grant amount Not stated — see the official call
Funding rate Charity research award; costs set by the RFA
View details → Breakthrough T1D United States Breakthrough T1D: Industry Discovery & Development Partnership (IDDP)
The Industry Discovery & Development Partnership (IDDP) Program provides funding to for-profit organizations conducting research projects that closely align with Breakthr…
Rolling — apply any time Deadline No fixed deadline
Grant amount Not stated — see the official call
Funding rate Partnership funding; terms agreed with the company
View details → U.S. National Science Foundation United States PD-16-1266
The Applied Mathematics program supports mathematics research motivated by and contributing to the solution of problems arising in science and engineering. Successful pro…
Open Deadline 16 Nov 2026 (in 1 day)
Grant amount Not stated — see the official call
Funding rate No mandatory cost sharing stated; funding percentage not stated
View details →